ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial.
Stephen T. Oh, M. Talpaz, A. Gerds, V. Gupta +14 more
Researcher profile · Semantic Scholar
Stephen T. Oh, M. Talpaz, A. Gerds, V. Gupta +14 more
N. Crum-Cianflone, L. Eberly, Yafeng Zhang, A. Ganesan +6 more
T. Giordano, G. Bartsch, Yafeng Zhang, E. Tedaldi +4 more
Chao Sun, Xinping Wang, Yafeng Zhang
Nicholas T. Funderburg, G. McComsey, M. Kulkarni, T. Bannerman +11 more
Yanxin Xu, Bo Shao, Yafeng Zhang
Rihao Ji, Yanfang Yang, Bohao Bian, Yafeng Zhang +2 more
Stephen T. Oh, M. Talpaz, A. Gerds, V. Gupta +13 more
R. García-Carbonero, R. Obermannova, G. Bodoky, J. Prausová +14 more
C. Brachmann, Yafeng Zhang, Marianna Zavodovskaya, Jing Hu +4 more
Zhi-Yu Chen, Gean Wu, Yizhe Fan, Chao Li +7 more
J. Metges, E. Elboudwarej, D. Cunningham, D. Catenacci +8 more
V. Gupta, R. Mesa, M. Deininger, C. Rivera +8 more
Zhe Li, Peng Wang, Yafeng Zhang, Jia-Xuan Zhang +6 more
C. Brachmann, Yafeng Zhang, E. Elboudwarej, S. Turner +8 more
Zhigang Liu, Chengyou Zhang, Yafeng Zhang, Xu Wu +1 more